Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
March 10, 2009

CTMM to Provide $319M in Funding for Eight R&D Projects in the Netherlands

  • The Center for Translational Molecular Medicine (CTMM) reported it will fund eight R&D projects on new techniques for the diagnosis and treatment of major diseases with almost €250 million, or $319 million. The Dutch government will contribute half the funding, with the rest coming from the industry and academia.

    The funding will be allocated to 13 university medical centers and research institutes, 29 SMEs (small- and medium-sized enterprises), and 15 industrial organizations.

    The newly approved projects include those that target cancer as well as cardiovascular, neurodegenerative, and infectious diseases, says the center. New technology platforms such as medical imaging techniques that can be applied across a broad spectrum of these diseases will also be developed.

    The CTMM says it will also continue to invest in centralized infrastructures for company projects to address the demand for advanced genomics, proteomics, metabolomics, and bioinformatics.

Related content

  • Finally! A cure for the Biotech News Blues.

  • Join 110,000 colleagues who rely on GEN Highlights for breaking news and exclusive articles shaping today’s life science tools and technologies.

  • Oops! Please type your email in the following format: yourname@example.com An error has occurred. Please contact Customer Service at contactGEN@genengnews.com
  • You’re all set! Thank you for subscribing to GEN Highlights.